Showing results (341-350 of 440) with videos related to

Sort By:
Pageof 44
Prostate Cancer and Prostatic Diseases|September 1, 2022
Is time to castration resistant prostate cancer a potential intermediate end-point for time to metastasis among men initiating androgen deprivation therapy for non-metastatic prostate cancer with rapid PSA doubling time (<9 months)?Zachary Klaassen, Lauren Howard, Christopher J D Wallis, et al.
BJU International|September 14, 2020
Can post-treatment free PSA ratio be used to predict adverse outcomes in recurrent prostate cancer?Hanan Goldberg, Rachel Glicksman, Dixon Woon, et al.
JMIR Formative Research|April 14, 2026
Coverage, Traits, and Geographic Distribution of Online Surgeon Reviews: Large-Scale Cross-Sectional AnalysisMichael Geng, Carlos Riveros, Yash B Shah, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|July 10, 2025
A population-based analysis of patterns of care in patients with high-risk non-muscle-invasive bladder cancer from Alberta, CanadaGeoffrey Gotto, Nimira S Alimohamed, Girish S Kulkarni, et al.
European Urology|May 17, 2020
Risks from Deferring Treatment for Genitourinary Cancers: A Collaborative Review to Aid Triage and Management During the COVID-19 PandemicChristopher J D Wallis, Giacomo Novara, Laura Marandino, et al.
JAMA Surgery|December 8, 2021
Association of Surgeon-Patient Sex Concordance With Postoperative OutcomesChristopher J D Wallis, Angela Jerath, Natalie Coburn, et al.
Urologic Oncology|January 7, 2023
Comparative real-world survival outcomes of metastatic papillary and clear cell renal cell carcinoma treated with immunotherapy, targeted therapy, and combination therapyCarlos Riveros, Sanjana Ranganathan, Jiaqiong Xu, et al.
Cancer|June 23, 2021
Assessment of gender representation in clinical trials leading to FDA approval for oncology therapeutics between 2014 and 2019: A systematic review-based cohort studyKyle A Dymanus, Mohit Butaney, Diana E Magee, et al.
European Urology Focus|July 5, 2020
The Suggested Unique Association Between the Various Statin Subgroups and Prostate CancerHanan Goldberg, Faizan K Mohsin, Refik Saskin, et al.
European Urology|March 9, 2023
Effect of Prior Local Therapy on Response to First-line Androgen Receptor Axis Targeted Therapy in Metastatic Castrate-resistant Prostate Cancer: A Secondary Analysis of the COU-AA-302 TrialSoumyajit Roy, Yilun Sun, Scott C Morgan, et al.
Pageof 44